SCHEMBL19939581

SCHEMBL19939581

Cc1c(OCCCN(C)Cc2ccccn2)cccc1-c1cccc(OCCCN2CCCC2)c1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.48
CYP2C19 P33261 2/20 0.48
CD274 Q9NZQ7 7/20 0.47
ALDH1A1 P00352 6/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
HTT P42858 1/20 0.43
KDM4E B2RXH2 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
PKM P14618 1/20 0.42
HRH3 Q9Y5N1 2/20 0.42
DRD2 P14416 1/20 0.42
DRD1 P21728 1/20 0.42
DRD5 P21918 1/20 0.42
HRH1 P35367 1/20 0.42
DRD3 P35462 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24445448 0.91 CYP2D6 (0.49) CYP2D6CYP2C19CD274ALDH1A1L3MBTL1
SCHEMBL19897863 0.86 CD274 (0.46) CD274ALDH1A1KDM4EHRH3
SCHEMBL19897858 0.86 CD274 (0.46) CD274ALDH1A1KDM4EHRH3
SCHEMBL19937850 0.85 CD274 (0.47) CYP2D6CYP2C19CD274ALDH1A1HRH3
SCHEMBL19937771 0.83 CYP2D6 (0.53) CYP2D6CYP2C19CD274ALDH1A1L3MBTL1
SCHEMBL19939517 0.82 CD274 (0.45) CYP2D6CYP2C19CD274ALDH1A1KDM4E
SCHEMBL19939389 0.82 CYP2D6 (0.52) CYP2D6CYP2C19CD274ALDH1A1L3MBTL1
SCHEMBL19937803 0.81 SCN8A (0.53) CYP2D6CYP2C19CD274ALDH1A1L3MBTL1
SCHEMBL16523580 0.80 HRH1 (0.54) CYP2D6CYP2C19ALDH1A1L3MBTL1KDM4E
SCHEMBL24445406 0.80 CYP2D6 (0.68) CYP2D6CYP2C19ALDH1A1L3MBTL1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3507284-B1 BIARYL COMPOUNDS USEFUL AS IMMUNOMODULATORS BRISTOL MYERS SQUIBB CO (US) 2022-05-25 EP disclosed
WO-2018044963-A1 BIARYL COMPOUNDS USEFUL AS IMMUNOMODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-03-08 WO disclosed